dual angiotensin II type 1 receptor antagonists/PPAR-gamma modulators (GlaxoSmithkline)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual angiotensin II type 1 receptor antagonists/PPAR-gamma modulators (GlaxoSmithkline)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsPeroxisome proliferator-activated receptor γ modulators
TargetsAngiotensin II Receptor Type 1Peroxisome proliferator-activated receptor γ
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxoSmithKline (France)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxoSmithKline (France)
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A